Swiss National Bank’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
131,000
+14,300
| +12% | +$163K | ﹤0.01% | 1956 |
|
|
2025
Q1 | $1.39M | Buy |
116,700
+9,800
| +9% | +$116K | ﹤0.01% | 1966 |
|
|
2024
Q4 | $2.01M | Hold |
106,900
| – | – | ﹤0.01% | 1848 |
|
|
2024
Q3 | $2.4M | Buy |
106,900
+7,700
| +8% | +$173K | ﹤0.01% | 1758 |
|
|
2024
Q2 | $2.07M | Buy |
+99,200
| New | +$2.07M | ﹤0.01% | 1794 |
|
|
2023
Q4 | – | Sell |
-84,800
| Closed | -$667K | – | 2584 |
|
|
2023
Q3 | $667K | Sell |
84,800
-3,100
| -4% | -$24.4K | ﹤0.01% | 2432 |
|
|
2023
Q2 | $878K | Buy |
87,900
+11,600
| +15% | +$116K | ﹤0.01% | 2361 |
|
|
2023
Q1 | $678K | Sell |
76,300
-8,900
| -10% | -$79K | ﹤0.01% | 2441 |
|
|
2022
Q4 | $935K | Buy |
85,200
+6,200
| +8% | +$68.1K | ﹤0.01% | 2380 |
|
|
2022
Q3 | $1.03M | Hold |
79,000
| – | – | ﹤0.01% | 2320 |
|
|
2022
Q2 | $1M | Buy |
79,000
+31,500
| +66% | +$399K | ﹤0.01% | 2366 |
|
|
2022
Q1 | $665K | Buy |
47,500
+3,500
| +8% | +$49K | ﹤0.01% | 2534 |
|
|
2021
Q4 | $1.27M | Hold |
44,000
| – | – | ﹤0.01% | 2328 |
|
|
2021
Q3 | $1.32M | Hold |
44,000
| – | – | ﹤0.01% | 2295 |
|
|
2021
Q2 | $1.17M | Buy |
44,000
+19,100
| +77% | +$507K | ﹤0.01% | 2420 |
|
|
2021
Q1 | $774K | Sell |
24,900
-200
| -0.8% | -$6.22K | ﹤0.01% | 2403 |
|
|
2020
Q4 | $825K | Buy |
+25,100
| New | +$825K | ﹤0.01% | 2369 |
|